Concepedia

Nusaïbah Ibrahimi

NI

Statistics

Publications

6

Citations

236

H-Index

6

Active since

2021

Affiliations

Institut Gustave Roussy(Current)

Inserm

Université Paris-Saclay

Assistance Publique – Hôpitaux de Paris

Institute for Research in Biomedicine

Nusaïbah Ibrahimi is an author at Institut Gustave Roussy specializing in medicine, oncology, and hormonal therapy.

Publications per year

2021–2023

6

Publications

6

High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer

Marta Palafox, Laia Monserrat, Meritxell Bellet et al. · Nature Communications · 2022 · 120 citations · Full text

Medicine, Oncology, Pharmacology +16

Delivering adapted physical activity by videoconference to patients with fatigue under immune checkpoint inhibitors: Lessons learned from the PACTIMe-FEAS feasibility study

Cécile Charles, A. Bardet, Nusaïbah Ibrahimi et al. · Journal of Telemedicine and Telecare · 2021 · 39 citations · Full text

Medicine, Health Sciences, Oncology +17

Dynamics of circulating calprotectin accurately predict the outcome of moderate COVID-19 patients

Nicolas Chapuis, Nusaïbah Ibrahimi, Thibaut Belmondo et al. · EBioMedicine · 2022 · 36 citations · Full text

Medicine, Geriatric Medicine, Clinical Epidemiology +14

189O A phase II study of patritumab deruxtecan (HER3-DXd), in patients (pts) with advanced breast cancer (ABC), with biomarker analysis to characterize response to therapy (ICARUS-BREAST01)

B. Pistilli, Nusaïbah Ibrahimi, M. Lacroix-Triki et al. · ESMO Open · 2023 · 19 citations · Full text

Medicine, Oncology, Pharmacology +17

High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer

Marta Palafox, Laia Monserrat, Meritxell Bellet et al. · Research Square · 2021 · 12 citations · Full text

Medicine, Oncology, Pharmacology +16

1–5 of 6